Daniel L Kraft
Overview
Explore the profile of Daniel L Kraft including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
540
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kraft D, Walck E, Carrasco A, Crocker M, Song L, Long M, et al.
Biol Blood Marrow Transplant
. 2019 Sep;
26(2):219-229.
PMID: 31491487
Bone marrow (BM) is a rich source of hematopoietic stem cells (HSCs), mesenchymal stem cells (MSCs), and other important stem/progenitor cells. It is the traditional source of cells used in...
2.
Blackburn P, Hickey R, Nace R, Giama N, Kraft D, Bordner A, et al.
Hum Mutat
. 2016 Jul;
37(10):1097-105.
PMID: 27397503
Tyrosinemia type I (TYRSN1, TYR I) is caused by fumarylacetoacetate hydrolase (FAH) deficiency and affects approximately one in 100,000 individuals worldwide. Pathogenic variants in FAH cause TYRSN1, which induces cirrhosis...
3.
Chan C, Lindau P, Jiang W, Chen J, Zhang L, Chen C, et al.
Proc Natl Acad Sci U S A
. 2013 Jul;
110(31):12643-8.
PMID: 23858471
Organs are composites of tissue types with diverse developmental origins, and they rely on distinct stem and progenitor cells to meet physiological demands for cellular production and homeostasis. How diverse...
4.
Sheikh A, Huber B, Narsinh K, Spin J, van der Bogt K, de Almeida P, et al.
Arterioscler Thromb Vasc Biol
. 2011 Oct;
32(1):92-102.
PMID: 22034515
Objective: Clinical trials of bone marrow-derived stem cell therapy for the heart have yielded variable results. The basic mechanism(s) that underlies their potential efficacy remains unknown. In the present study,...
5.
Li Z, Wilson K, Smith B, Kraft D, Jia F, Huang M, et al.
PLoS One
. 2010 Jan;
4(12):e8443.
PMID: 20046878
Background: Differentiation of human embryonic stem cells into endothelial cells (hESC-ECs) has the potential to provide an unlimited source of cells for novel transplantation therapies of ischemic diseases by supporting...
6.
Chan C, Chen C, Luppen C, Kim J, DeBoer A, Wei K, et al.
Nature
. 2008 Dec;
457(7228):490-4.
PMID: 19078959
Little is known about the formation of niches, local micro-environments required for stem-cell maintenance. Here we develop an in vivo assay for adult haematopoietic stem-cell (HSC) niche formation. With this...
7.
Soen Y, Chen D, Kraft D, Davis M, Brown P
PLoS Biol
. 2003 Dec;
1(3):E65.
PMID: 14691537
The detection and characterization of antigen-specific T cell populations is critical for understanding the development and physiology of the immune system and its responses in health and disease. We have...
8.
Park W, OBrien J, Lundquist P, Kraft D, Walsh Vockley C, Karnes P, et al.
Hum Mutat
. 2003 Sep;
22(4):313-25.
PMID: 12955717
The two known complementation groups of Niemann-Pick Type C disease, NPC1 and NPC2, result from non-allelic protein defects. Both the NPC1 and NPC2 (HE1) gene products are intimately involved in...